Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia
暂无分享,去创建一个
F. Bezanilla | R. Latorre | C. Gomez | J. Carvalho-de-Souza | J. Staisch | T. Kubota | Willy Carrasquel-Ursulaez | Xiaofei Du | Y. Lorenzo | Cenfu Wei | Mingjia Xu | Naileth Gonzalez | Timothy Hain | N. Petrossian | Natalie Petrossian
[1] S. Keros,et al. KCNMA1-linked channelopathy , 2019, The Journal of general physiology.
[2] G. Mancini,et al. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes. , 2019, Human molecular genetics.
[3] Y. Bayram,et al. Expanding the Phenotype of Homozygous KCNMA1 Mutations; Dyskinesia, Epilepsy, Intellectual Disability, Cerebellar and Corticospinal Tract Atrophy , 2018, Balkan medical journal.
[4] Qiuyun Chen,et al. De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca2+ sensitivity , 2018, European Journal of Human Genetics.
[5] R. MacKinnon,et al. Cryo-EM structure of the open high-conductance Ca2+-activated K+ channel , 2016, Nature.
[6] G. Carvill,et al. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy , 2016, Neurology.
[7] D. Andrade,et al. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations. , 2016, Epileptic disorders : international epilepsy journal with videotape.
[8] Sharyn A. Lincoln,et al. BRAT1 mutations present with a spectrum of clinical severity , 2016, American journal of medical genetics. Part A.
[9] F. Alkuraya,et al. Homozygous KCNMA1 mutation as a cause of cerebellar atrophy, developmental delay and seizures , 2016, Human Genetics.
[10] C. Gomez,et al. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron , 2016, Science Translational Medicine.
[11] C. Duyckaerts,et al. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. , 2015, American journal of human genetics.
[12] F. Orzi,et al. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial , 2015, The Lancet Neurology.
[13] H. Orr,et al. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability , 2015, The Journal of Neuroscience.
[14] Yu-wu Jiang,et al. De novo KCNMA1 mutations in children with early‐onset paroxysmal dyskinesia and developmental delay , 2015, Movement disorders : official journal of the Movement Disorder Society.
[15] S. Züchner,et al. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy , 2015, BMC Medical Genetics.
[16] A. Durr,et al. Erratum to: The L450P mutation in KCND3 brings spinocerebellar ataxia and Brugada syndrome closer together , 2015, neurogenetics.
[17] Y. Sekino,et al. Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells , 2014, The Journal of physiology.
[18] A. Durr,et al. The L450P mutation in KCND3 brings spinocerebellar ataxia and Brugada syndrome closer together , 2013, neurogenetics.
[19] Jun Wang,et al. Second Cistron in CACNA1A Gene Encodes a Transcription Factor Mediating Cerebellar Development and SCA6 , 2013, Cell.
[20] E. Stefani,et al. mitoBKCa is encoded by the Kcnma1 gene, and a splicing sequence defines its mitochondrial location , 2013, Proceedings of the National Academy of Sciences.
[21] I. Adzhubei,et al. Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.
[22] C. Wijmenga,et al. Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19 , 2012, Annals of neurology.
[23] E. Stefani,et al. Intracellular BKCa (iBKCa) channels , 2012, The Journal of physiology.
[24] S. Heinemann,et al. Molecular mechanism of pharmacological activation of BK channels , 2012, Proceedings of the National Academy of Sciences.
[25] C Marelli,et al. Autosomal dominant cerebellar ataxias. , 2011, Revue neurologique.
[26] S. Pulst,et al. Frequency of KCNC3 DNA Variants as Causes of Spinocerebellar Ataxia 13 (SCA13) , 2011, PloS one.
[27] M. Salvetti,et al. Riluzole in cerebellar ataxia , 2010, Neurology.
[28] S. Pulst,et al. KCNC3: phenotype, mutations, channel biophysics—a study of 260 familial ataxia patients , 2010, Human mutation.
[29] M. Womack,et al. Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neurons , 2009, Neuroscience.
[30] M. D’Adamo,et al. Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1. , 2007, American journal of physiology. Cell physiology.
[31] Lippincott Williams Wilkins,et al. Scale for the assessment and rating of ataxia: Development of a new clinical scale , 2006, Neurology.
[32] A. Durr,et al. Scale for the assessment and rating of ataxia , 2006, Neurology.
[33] Jianmin Cui,et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder , 2005, Nature Genetics.
[34] H. Nakaya,et al. Mitochondrial Ca2+-Activated K+ Channels in Cardiac Myocytes: A Mechanism of the Cardioprotective Effect and Modulation by Protein Kinase A , 2005, Circulation.
[35] N. Longo,et al. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy , 2004, Journal of Inherited Metabolic Disease.
[36] J F Storm,et al. Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Zatz,et al. The 10 autosomal recessive limb-girdle muscular dystrophies , 2003, Neuromuscular Disorders.
[38] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[39] Sheng-Nan Wu,et al. Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells , 2003, Brain Research.
[40] Yongge Liu,et al. Cytoprotective Role of Ca2+- Activated K+ Channels in the Cardiac Inner Mitochondrial Membrane , 2002, Science.
[41] M. Womack,et al. Characterization of large conductance Ca2+‐activated K+ channels in cerebellar Purkinje neurons , 2002, The European journal of neuroscience.
[42] E. Marbán,et al. Mitochondrial ATP-Sensitive Potassium Channels Attenuate Matrix Ca2+ Overload During Simulated Ischemia and Reperfusion , 2001 .
[43] M. D’Adamo,et al. Mutations in the KCNA1 gene associated with episodic ataxia type‐1 syndrome impair heteromeric voltage‐gated K+ channel function , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] J. Jen. Calcium channelopathies in the central nervous system , 1999, Current Opinion in Neurobiology.
[45] J. Adelman,et al. Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel , 1998, FEBS letters.
[46] Dennis E Bulman,et al. Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4 , 1996, Cell.
[47] N. Standen,et al. Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle , 1996, British journal of pharmacology.
[48] G. Edwards,et al. Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle , 1994, British journal of pharmacology.
[49] Michael Litt,et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1 , 1994, Nature Genetics.
[50] R. MacKinnon,et al. Mutations in the K+ channel signature sequence. , 1994, Biophysical journal.
[51] S. Olesen,et al. Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone. , 1994, European journal of pharmacology.
[52] K. Gunter,et al. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. , 1990, The Biochemical journal.
[53] F Bezanilla,et al. Inactivation of the sodium channel. II. Gating current experiments , 1977, The Journal of general physiology.
[54] Osvaldo Alvarez,et al. Molecular Determinants of BK Channel Functional Diversity and Functioning. , 2017, Physiological reviews.
[55] T. Gao,et al. Functional Role of Mitochondrial and Nuclear BK Channels. , 2016, International review of neurobiology.
[56] Francisco Bezanilla,et al. Inactivation of the Sodium Channel , 2003 .
[57] G. A. Moore,et al. randomised double blind placebo controlled trial , 2022 .